OmniTier’s Genomic Analysis Platform Improved Diagnostics Rate for Rare Diseases
The NCCHD in Japan and OmniTier detailed how the company’s genomic analysis platform improved diagnostic rates for rare diseases.
Read More
Search Results for: liver disease
OncoHost Launches NSCLC Test in the U.S.
OncoHost, a diagnostics company centered on predictive biomarker development patient care, launched its non-small lung cancer (NSCLC) test.
Read More
AI Can Help Patients Interpret COVID Home Tests
New machine learning research provides a way to predict if respiratory symptoms are caused by COVID, influenza, or RSV.
Read More
Making Hepatitis C Diagnosis Accessible Via Point-of-Care HCV Viral Load Assays
A new study shows the benefits of using a quick clinic-based diagnostic test for hepatitis C virus infection over a standard lab-based test.
Read More
Thermo Fisher Scientific, AstraZeneca to Develop Solid Tissue and Blood-Based CDx Test for Tagrisso
Thermo Fisher Scientific is working with AstraZeneca to develop a solid tissue and blood-based companion diagnostic test for Tagrisso.
Read More